Revenue
1.27 million USD
2024 Q3 · USD
Exact inputs and evidence
- Revenue: 1269373 USD Source
18 filing records in this dataset, filed from 2021-12-16 to 2025-06-11. Reported financial figures are available; chart coverage varies by period.
1.27 million USD
2024 Q3 · USD
-94.86%
2024 Q3 · %
895 thousand USD
2024 Q3 · USD
31703 USD
3239177 USD
7090728 shares
1,022.66% · 6.46 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-18.2 million USD
2023-10-01 – 2024-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2025-06-11.
Financial data available through: 2023-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 15.9 million
–
Current period
USD 8.23 million
–
8225792 − 15902529 = -7676737 USD
15902529 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source8225792 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 29.98 million
–
Current period
−USD 22.7 million
–
-22700000 − -29977816 = 7277816 USD
-29977816 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-22700000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 9.69 million
–
Current period
−USD 5.8 million
–
-5800000 − -9685871 = 3885871 USD
-9685871 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-5800000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | 1959595 | 3861329 Derived | -1901734 | 1267284 Derived | -3169018 | -2013528 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 9022593 | 14263414 Derived | -5240821 | 2524702 Derived | -7765523 | -5106841 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 15902529 | 27853510 Derived | -11950981 | 18026835 Derived | -29977816 | -9715591 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 8225792 | 25381784 Derived | -17155992 | 5544008 Derived | -22700000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Revenue | 1959595 |
|
| 2021 | Revenue | 9022593 |
|
| 2022 | Revenue | 15902529 |
|
| 2023 | Revenue | 8225792 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | 360.4% |
|
| 2022 | Year over year | 76.3% |
|
| 2023 | Year over year | -48.3% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Operating margin | -97% |
|
| 2021 | Operating margin | -58.1% |
|
| 2022 | Operating margin | -75.2% |
|
| 2023 | Operating margin | -208.6% |
|
| 2020 | Net margin | -161.7% |
|
| 2021 | Net margin | -86.1% |
|
| 2022 | Net margin | -188.5% |
|
| 2023 | Net margin | -276% |
|
| 2020 | Free cash flow margin | -102.8% |
|
| 2021 | Free cash flow margin | -56.6% |
|
| 2022 | Free cash flow margin | -61.1% |
|
| 2023 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Operating cash flow | -1980562 |
|
| 2021 | Operating cash flow | -4965458 |
|
| 2022 | Operating cash flow | -9685871 |
|
| 2023 | Operating cash flow | -5800000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Free cash flow | -2013528 |
|
| 2021 | Free cash flow | -5106841 |
|
| 2022 | Free cash flow | -9715591 |
|
| 2023 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Liabilities / assets | 477.2% |
|
| 2021 | Liabilities / assets | 126.9% |
|
| 2022 | Liabilities / assets | 108.1% |
|
| 2023 | Liabilities / assets | 132.5% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Current assets / current liabilities | 0.1× |
|
| 2021 | Current assets / current liabilities | 0.25× |
|
| 2022 | Current assets / current liabilities | 0.24× |
|
| 2023 | Current assets / current liabilities | 0.11× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | −USD 3.17 million Exact valueExact value: -3169018 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.98 million Exact valueExact value: -1980562 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 32,966 Exact valueExact value: 32966 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.01 million Calculation and evidence-1980562 − 32966 USD Exact free cash flow: -2013528 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 7.77 million Exact valueExact value: -7765523 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.97 million Exact valueExact value: -4965458 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 141,383 Exact valueExact value: 141383 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.11 million Calculation and evidence-4965458 − 141383 USD Exact free cash flow: -5106841 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 29.98 million Exact valueExact value: -29977816 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.69 million Exact valueExact value: -9685871 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 29,720 Exact valueExact value: 29720 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.72 million Calculation and evidence-9685871 − 29720 USD Exact free cash flow: -9715591 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 22.7 million Exact valueExact value: -22700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.8 million Exact valueExact value: -5800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
18 filings · 1,039 latest values · 1,039 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001851860, 1851860, SMFL, edgar:1851860
Also known as Bonne Sante Group, Inc., SMART FOR LIFE, INC, SMART FOR LIFE, INC.